FeesSafety
Pluang+

Standard Uranium closes final tranche of $2.585M LIFE offering, raising $500K in latest flow-through units sale

Company Fundamentals
20 Nov 2026, 02:15 WIB
Proactive Investors
View Source
Bullish
Standard Uranium closes final tranche of $2.585M LIFE offering, raising $500K in latest flow-through units sale

Standard Uranium Ltd has completed the final tranche of its LIFE offering, raising an additional $500,000 through the sale of 6.25 million flow-through units priced at $0.08 each. This brings the total gross proceeds from the offering to $2.585 million, with 32.3 million flow-through units issued in total. Each unit includes one common share and half a warrant, allowing holders to buy shares at $0.12 until November 2028, exercisable from January 2027. This funding supports the company's uranium mining projects and growth plans.

Standard Uranium's recent financing round is context for readers following Basic Materials. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 20, 2026 07:21 WIB: of 83 priced Basic Materials-sector US stocks tradable on Pluang, 5 rose and 77 fell today. FMC Corp was down 8.55% at USD 4.28 with 0% Sell / 100% Buy order activity, Endeavour Silver Corp fell 8.54% to USD 6.00 with the same buy order activity, and Americas Gold and Silver Corporation dropped 6.91% to USD 2.02 with 0% Sell / 100% Buy order activity.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App